These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
201 related articles for article (PubMed ID: 22371402)
21. Uterine leiomyoma cytogenetics. II. Report of forty cases. Vanni R; Lecca U; Faa G Cancer Genet Cytogenet; 1991 Jun; 53(2):247-56. PubMed ID: 2065298 [TBL] [Abstract][Full Text] [Related]
22. Endocrinology of uterine fibroids: steroid hormones, stem cells, and genetic contribution. Moravek MB; Bulun SE Curr Opin Obstet Gynecol; 2015 Aug; 27(4):276-83. PubMed ID: 26107781 [TBL] [Abstract][Full Text] [Related]
23. Lipopolysaccharide activated TLR4/NF-κB signaling pathway of fibroblasts from uterine fibroids. Guo J; Zheng L; Chen L; Luo N; Yang W; Qu X; Liu M; Cheng Z Int J Clin Exp Pathol; 2015; 8(9):10014-25. PubMed ID: 26617709 [TBL] [Abstract][Full Text] [Related]
24. Human leiomyoma smooth muscle cells show increased expression of transforming growth factor-beta 3 (TGF beta 3) and altered responses to the antiproliferative effects of TGF beta. Lee BS; Nowak RA J Clin Endocrinol Metab; 2001 Feb; 86(2):913-20. PubMed ID: 11158066 [TBL] [Abstract][Full Text] [Related]
26. Different karyotypic abnormalities, t(1;6) and del(7), in two uterine leiomyomas from the same patient. Nilbert M; Heim S; Mandahl N; Flodérus UM; Willén H; Mitelman F Cancer Genet Cytogenet; 1989 Oct; 42(1):51-3. PubMed ID: 2790746 [TBL] [Abstract][Full Text] [Related]
27. Loss of the repressor REST in uterine fibroids promotes aberrant G protein-coupled receptor 10 expression and activates mammalian target of rapamycin pathway. Varghese BV; Koohestani F; McWilliams M; Colvin A; Gunewardena S; Kinsey WH; Nowak RA; Nothnick WB; Chennathukuzhi VM Proc Natl Acad Sci U S A; 2013 Feb; 110(6):2187-92. PubMed ID: 23284171 [TBL] [Abstract][Full Text] [Related]
28. Increased expression of calcium-binding protein S100 in human uterine smooth muscle tumours. Kanamori T; Takakura K; Mandai M; Kariya M; Fukuhara K; Sakaguchi M; Huh NH; Saito K; Sakurai T; Fujita J; Fujii S Mol Hum Reprod; 2004 Oct; 10(10):735-42. PubMed ID: 15322223 [TBL] [Abstract][Full Text] [Related]
29. Deletion 7q22 in uterine leiomyoma. A cytogenetic review. Ozisik YY; Meloni AM; Surti U; Sandberg AA Cancer Genet Cytogenet; 1993 Nov; 71(1):1-6. PubMed ID: 8275445 [TBL] [Abstract][Full Text] [Related]
30. Relative overexpression of the parathyroid hormone-related protein gene in human leiomyomas. Weir EC; Goad DL; Daifotis AG; Burtis WJ; Dreyer BE; Nowak RA J Clin Endocrinol Metab; 1994 Mar; 78(3):784-9. PubMed ID: 8126157 [TBL] [Abstract][Full Text] [Related]
31. Expression of steroid receptor coactivators in cultured cells from paired myometrial and fibroid tissues. Hussein-Fikret S; Fuller PJ; Gargett CE J Soc Gynecol Investig; 2005 Sep; 12(6):445-51. PubMed ID: 15979354 [TBL] [Abstract][Full Text] [Related]
32. Decreased expression of early growth response-1 and its role in uterine leiomyoma growth. Shozu M; Murakami K; Segawa T; Kasai T; Ishikawa H; Shinohara K; Okada M; Inoue M Cancer Res; 2004 Jul; 64(13):4677-84. PubMed ID: 15231681 [TBL] [Abstract][Full Text] [Related]
33. Molecular and Cellular Insights into the Development of Uterine Fibroids. Machado-Lopez A; Simón C; Mas A Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445194 [TBL] [Abstract][Full Text] [Related]
34. Molecular and cytogenetic analysis of chromosome 7 in uterine leiomyomas. Ishwad CS; Ferrell RE; Davare J; Meloni AM; Sandberg AA; Surti U Genes Chromosomes Cancer; 1995 Sep; 14(1):51-5. PubMed ID: 8527384 [TBL] [Abstract][Full Text] [Related]
35. The role of angiogenic factors in fibroid pathogenesis: potential implications for future therapy. Tal R; Segars JH Hum Reprod Update; 2014; 20(2):194-216. PubMed ID: 24077979 [TBL] [Abstract][Full Text] [Related]
36. Pathology, cytogenetics and molecular biology of uterine leiomyomas and other smooth muscle lesions. Quade BJ Curr Opin Obstet Gynecol; 1995 Feb; 7(1):35-42. PubMed ID: 7742513 [TBL] [Abstract][Full Text] [Related]
37. The Role of Tumor Necrosis Factor α in the Biology of Uterine Fibroids and the Related Symptoms. Ciebiera M; Włodarczyk M; Zgliczyńska M; Łukaszuk K; Męczekalski B; Kobierzycki C; Łoziński T; Jakiel G Int J Mol Sci; 2018 Dec; 19(12):. PubMed ID: 30518097 [TBL] [Abstract][Full Text] [Related]
39. Chromosomal translocations affecting 12q14-15 but not deletions of the long arm of chromosome 7 associated with a growth advantage of uterine smooth muscle cells. Hennig Y; Deichert U; Bonk U; Thode B; Bartnitzke S; Bullerdiek J Mol Hum Reprod; 1999 Dec; 5(12):1150-4. PubMed ID: 10587370 [TBL] [Abstract][Full Text] [Related]
40. The del(7q) subgroup in uterine leiomyomata: genetic and biologic characteristics. Further evidence for the secondary nature of cytogenetic abnormalities in the pathobiology of uterine leiomyomata. Xing YP; Powell WL; Morton CC Cancer Genet Cytogenet; 1997 Oct; 98(1):69-74. PubMed ID: 9309121 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]